Lisa Gill
Stock Analyst at JP Morgan
(3.27)
# 1,036
Out of 5,149 analysts
139
Total ratings
51.06%
Success rate
1.82%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDRX GoodRx Holdings | Downgrades: Neutral | n/a | $2.07 | - | 3 | Feb 27, 2026 | |
| LH Labcorp Holdings | Maintains: Overweight | $319 → $330 | $282.99 | +16.61% | 4 | Feb 18, 2026 | |
| CAH Cardinal Health | Maintains: Neutral | $209 → $243 | $226.35 | +7.36% | 7 | Feb 10, 2026 | |
| COR Cencora | Maintains: Overweight | $417 → $419 | $371.44 | +12.80% | 4 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Overweight | $983 → $1,107 | $995.69 | +11.18% | 15 | Feb 10, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $394 → $397 | $284.03 | +39.77% | 7 | Feb 2, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $289.21 | +34.50% | 11 | Feb 2, 2026 | |
| MDLN Medline | Initiates: Overweight | $50 | $44.39 | +12.64% | 1 | Jan 12, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $80.49 | +25.48% | 6 | Dec 17, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $23 | $18.45 | +24.66% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $33 | $23.77 | +38.83% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $17.52 | +48.40% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $283.93 | +32.07% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $7.28 | +37.36% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $208.36 | -8.81% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $23.48 | +27.77% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $31.20 | +31.41% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $181.58 | +40.98% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $36.87 | -51.18% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $9.49 | -47.31% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $13.92 | +101.15% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $9 | $5.10 | +76.47% | 9 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $9.41 | +91.29% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $144.81 | +172.77% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $204.85 | -9.20% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $242.88 | -42.36% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $541.80 | -38.72% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.57 | +1,486.18% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $7.27 | +10.04% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $80.21 | +3.48% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $43.82 | +123.64% | 1 | Jan 6, 2023 |
GoodRx Holdings
Feb 27, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.07
Upside: -
Labcorp Holdings
Feb 18, 2026
Maintains: Overweight
Price Target: $319 → $330
Current: $282.99
Upside: +16.61%
Cardinal Health
Feb 10, 2026
Maintains: Neutral
Price Target: $209 → $243
Current: $226.35
Upside: +7.36%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $371.44
Upside: +12.80%
McKesson
Feb 10, 2026
Maintains: Overweight
Price Target: $983 → $1,107
Current: $995.69
Upside: +11.18%
Elevance Health
Feb 2, 2026
Maintains: Overweight
Price Target: $394 → $397
Current: $284.03
Upside: +39.77%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $289.21
Upside: +34.50%
Medline
Jan 12, 2026
Initiates: Overweight
Price Target: $50
Current: $44.39
Upside: +12.64%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $80.49
Upside: +25.48%
Alignment Healthcare
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $18.45
Upside: +24.66%
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $23.77
Upside: +38.83%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $17.52
Upside: +48.40%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $283.93
Upside: +32.07%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $7.28
Upside: +37.36%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $208.36
Upside: -8.81%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $23.48
Upside: +27.77%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $31.20
Upside: +31.41%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $181.58
Upside: +40.98%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $36.87
Upside: -51.18%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $9.49
Upside: -47.31%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $13.92
Upside: +101.15%
Aug 26, 2024
Maintains: Neutral
Price Target: $16 → $9
Current: $5.10
Upside: +76.47%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $9.41
Upside: +91.29%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $144.81
Upside: +172.77%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $204.85
Upside: -9.20%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $242.88
Upside: -42.36%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $541.80
Upside: -38.72%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.57
Upside: +1,486.18%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $7.27
Upside: +10.04%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $80.21
Upside: +3.48%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $43.82
Upside: +123.64%